Oligoastrocytoma
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Oligoastrocytoma, NOS is an uncommon neuropathology tumour that is no longer a distinct entity.[1]
General
- Mixed tumour by definition.
- After IDH-1/2 mutation screening and LOH 1p/19q analysis almost all tumors are either classified as oligodendroglioma or astrocytoma.[1]
- The NOS category is reserved for cases without genetic testing.[2]
Two types exist:
- Oligoastrocytoma, NOS (Grade II WHO; ICD-O: 9382/3)
- Anaplastic Oligoastrocytoma, NOS (Grade III WHO; ICD-O: 9382/3)
Microscopic
Features:
- Astrocytoma-like and oligodendroglioma-like:
- Oligodendroglioma-like cells = round nucleus, peri-nuclear clearing.
- Astrocytoma-like cells = non-ovoid/elongated nucleus.
DDx:
- Anaplastic astrocytoma.
- Oligodendroglioma.
- Diffuse astrocytoma.
- Anaplastic oligodendroglioma
- Glioblastoma
IHC
- Oligodendroglioma-like cells: MAP2 +ve (cytoplasm).
- Astrocytoma-like cells: GFAP +ve (cytoplasm, nuclear membrane).
Others:
- Ki-67 3-10%.
- ATRX loss (in cases without LOH1p/19q).
- IDH-1 +ve. (85%).
See also
References
- ↑ 1.0 1.1 Sahm, F.; Reuss, D.; Koelsche, C.; Capper, D.; Schittenhelm, J.; Heim, S.; Jones, DT.; Pfister, SM. et al. (Oct 2014). "Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.". Acta Neuropathol 128 (4): 551-9. doi:10.1007/s00401-014-1326-7. PMID 25143301.
- ↑ Louis, DN.; Perry, A.; Reifenberger, G.; von Deimling, A.; Figarella-Branger, D.; Cavenee, WK.; Ohgaki, H.; Wiestler, OD. et al. (Jun 2016). "The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.". Acta Neuropathol 131 (6): 803-20. doi:10.1007/s00401-016-1545-1. PMID 27157931.